Cigna Group

For the period ended Mar 31, 2025. Filed May 2, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 2, 2025

CI$295.60+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Earnings Per Share

Note 6 – Earnings Per Share

Basic and diluted earnings per share were computed as follows:

	Three Months Ended
March 31, 2025 · March 31, 2024
(Shares in thousands, dollars in millions, except per share amounts) · Basic · Effect ofDilution · Diluted · Basic · Effect ofDilution · Diluted
Shareholders' net income (loss)	$1,323			$1,323		$(277)				$(277)
Shares:
Weighted average	270,867			270,867		286,465				286,465
Common stock equivalents		2,086		2,086				—		—
Total shares	270,867		2,086		272,953		286,465		—		286,465
Earnings per share	$4.88		$(0.03)		$4.85		$(0.97)		$—		$(0.97)

For the three months ended March 31, 2025,2.3 million outstanding employee stock options were excluded in the computation of diluted earnings per share because their effect was anti-dilutive. For the three months ended March 31, 2024, due to the Shareholders' net loss,8.2 million outstanding employee stock options, unvested restricted stock grants and units, and strategic performance shares were excluded in the computation of diluted earnings per share because their effect was anti-dilutive.

The Company held approximately 134.1 million shares of common stock in treasury as of March 31, 2025,128.7 million shares as of December 31, 2024 and 117.8 million shares as of March 31, 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.